Epcoritamab Greenlit as R2 Add-On for R/R FL



FDA clears first bispecific antibody for combination use in relapsed or refractory follicular lymphoma.
Medscape Medical News



Source link : https://www.medscape.com/viewarticle/epcoritamab-greenlit-r2-add-r-r-fl-2025a1000w7r?src=rss

Author :

Publish date : 2025-11-19 10:10:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version